Eli Lilly & Co. (LLY)
1122.13
-0.87
(-0.08%)
USD |
NYSE |
Sep 11, 13:46
Eli Lilly Gross Profit (TTM) : 66.44B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 66.44B |
| March 31, 2026 | 59.84B |
| December 31, 2025 | 54.13B |
| September 30, 2025 | 49.34B |
| June 30, 2025 | 44.01B |
| March 31, 2025 | 40.03B |
| December 31, 2024 | 36.62B |
| September 30, 2024 | 33.06B |
| June 30, 2024 | 31.43B |
| March 31, 2024 | 28.80B |
| December 31, 2023 | 27.04B |
| September 30, 2023 | 25.23B |
| June 30, 2023 | 22.95B |
| March 31, 2023 | 21.51B |
| December 31, 2022 | 21.91B |
| September 30, 2022 | 22.11B |
| June 30, 2022 | 22.09B |
| March 31, 2022 | 21.82B |
| December 31, 2021 | 21.01B |
| September 30, 2021 | 20.78B |
| June 30, 2021 | 19.85B |
| March 31, 2021 | 19.34B |
| December 31, 2020 | 19.06B |
| September 30, 2020 | 18.17B |
| June 30, 2020 | 18.06B |
| Date | Value |
|---|---|
| March 31, 2020 | 18.29B |
| December 31, 2019 | 17.60B |
| September 30, 2019 | 17.27B |
| June 30, 2019 | 17.13B |
| March 31, 2019 | 16.97B |
| December 31, 2018 | 16.81B |
| September 30, 2018 | 16.84B |
| June 30, 2018 | 16.78B |
| March 31, 2018 | 16.70B |
| December 31, 2017 | 16.80B |
| September 30, 2017 | 16.56B |
| June 30, 2017 | 16.26B |
| March 31, 2017 | 15.93B |
| December 31, 2016 | 15.57B |
| September 30, 2016 | 15.26B |
| June 30, 2016 | 15.19B |
| March 31, 2016 | 15.01B |
| December 31, 2015 | 14.92B |
| September 30, 2015 | 14.80B |
| June 30, 2015 | 14.69B |
| March 31, 2015 | 14.67B |
| December 31, 2014 | 14.68B |
| September 30, 2014 | 15.24B |
| June 30, 2014 | 16.20B |
| March 31, 2014 | 17.22B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Johnson & Johnson | 66.63B |
| Merck & Co., Inc. | 48.01B |
| Pfizer Inc. | 41.30B |
| Bristol Myers Squibb Co. | 32.78B |
| Atai Beckley, Inc. | 2.792M |